What GHK-Cu is
Glycyl-histidyl-lysine bound to a copper ion – a fragment released when certain proteins break down, discovered in human plasma in the 1970s. Plasma levels fall substantially between youth and later adulthood.
What the research explores
Laboratory and small human studies have examined GHK-Cu's role in collagen-related signaling and skin appearance – the reason it appears in dermatology research and cosmetic formulations. Human clinical evidence remains limited, and no outcome is promised.
Topical versus injectable
Topical creams target skin directly and are the most common form. Injectable GHK-Cu exists in clinician-guided programs; which form, if any, is appropriate depends on your goals and history.
Finasteride is FDA-approved as a brand product for androgenetic alopecia in men.
The compliance fine print
GHK-Cu is not FDA-approved for any indication. When prescribed, compounded preparations are made by licensed US pharmacies for an individual patient. A licensed clinician decides whether it is appropriate – and 'peptide' describes chemistry, not proof of effect. See the 30-second film answers for this medication.
How GHK-Cu is described to work
GHK-Cu is a tripeptide, glycyl-L-histidyl-L-lysine, bound to a copper ion. The peptide occurs naturally in human plasma and declines with age. In laboratory and animal work it has been associated with signalling related to collagen synthesis, wound repair, and antioxidant activity, and the copper ion is itself a cofactor for lysyl oxidase, an enzyme involved in cross-linking collagen. That is a mechanistically coherent story, and it is largely preclinical. Human clinical evidence for cosmetic or therapeutic outcomes from compounded GHK-Cu is limited. Compounded preparations are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. How to use GHK-Cu covers the practical handling; whether it is appropriate for you is a clinician’s decision.
Routes, handling, and what the instructions govern
GHK-Cu is prepared topically and, in some compounded formulations, for injection, and the handling requirements differ accordingly. Copper peptide preparations are generally kept cool and away from light, because both temperature and light drive degradation, and the dispensing pharmacy sets the storage and beyond-use instructions for your specific preparation. Those instructions govern over anything written on a website. Do not use a preparation whose colour or clarity has changed. GHK-Cu dosing covers what is described in practice, all of it set by the prescribing clinician rather than by a published standard.
What is not established, stated plainly
The mechanistic case for GHK-Cu rests largely on laboratory and animal work. Human clinical trial evidence for cosmetic or wound-healing outcomes from compounded preparations is limited, and compounded preparations are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing. Copper is also a mineral with a genuine upper limit, so anyone with Wilson’s disease or a copper metabolism disorder should raise that specifically. A clinician weighs the uncertainty against your history and may decline.
What to ask before starting a copper peptide
Three questions separate a considered decision from a purchase. First, what is the evidence base for the specific outcome being described, and for compounded GHK-Cu the honest answer is that most of it is preclinical. Second, which licensed pharmacy compounds and dispenses this preparation, and is that pharmacy named and verifiable. Third, what would the clinician consider a reason to stop. Compounded preparations are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing. Red flags when buying online covers how to evaluate a seller, and a licensed clinician decides whether treatment is appropriate for you at all.
Answer a few questions. A licensed clinician decides what, if anything, is appropriate.
Frequently asked questions
Is GHK-Cu FDA approved?
No. It is not an FDA-approved drug, and compounded preparations are not reviewed by FDA before marketing.
Where is it used on the body?
Topical use targets the skin it touches. Injection protocols are clinician-directed – dosing questions belong to your prescriber and your dispensed instructions, not internet averages.
Is it safe?
It occurs naturally in your plasma, but concentrated use is a medical decision. That is why evaluation comes first.
What is GHK-Cu?
A tripeptide, glycyl-L-histidyl-L-lysine, bound to a copper ion. It occurs naturally in human plasma and declines with age.
Does GHK-Cu work?
Laboratory and animal work associates it with collagen synthesis and wound-repair signalling. Human clinical evidence for compounded preparations is limited, and they are not FDA-approved.
How do you use GHK-Cu?
Follow the route and instructions supplied with your preparation. A licensed clinician determines whether it is appropriate for you.
Curious about GHK-Cu? Start with an evaluation
A licensed clinician reviews your history and decides what is appropriate. Rx only, refunded in full if you are not prescribed.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- Peer-reviewedPickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci 2018;19(7):1987
- FDAFDA. Compounding and the FDA: questions and answers
- Research databaseSearch the literature: GHK-Cu peptide research
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on GHK-Cu
Same medication, different question.
